Abstract
Over 2000 allogeneic bone marrow transplants are reported in persons with acute lymphoblastic leukemia [reviewed in 1–6]. Results depend on remission status and age and are summarized in Table 1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gale RP, Kersey JH, Bortin MM, et al. Bone marrow transplantation for acute lymphoblastic leukemia. Lancet 1983; 2:663–667.
Report from the Working Party on Leukemia, European Group for Bone Marrow Transplantation. Allogeneic bone marrow transplantation for leukemia in Europe. Lancet 1988; 2:1379–1382.
Barrett AJ, Kendra JR, Lucas CF, et al. Bone marrow transplantation for acute lymphoblastic leukemia. Br J Haematol 1982; 52:181–188.
Kersey JH, Weisdorf D, Nesbit ME, et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 1987; 317:461–467.
Sanders JE, Thomas ED, Buckner CD, Doney K. Marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 1987; 70:324–326.
Barrett AJ, Horowitz MM, Gale RP, et al. Bone marrow transplantation for acute lymphoblastic leukemia: Leukemia relapse and prophylaxis graft-versus-host disease. Submitted.
Woods EG, Nesbit ME, Ramsay NKC, et al. Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: Determination of prognostic factors. Blood 1983; 61:1182–1189.
Barrett AJ, Joshi R, Kencha JR, et al. Prediction and prevention of relapse of acute lymphoblastic leukemia after bone marrow transplantation. Br J Haematol 1986; 64:179–186.
Johnson FL, Thomas ED, Clark BS, Chard RL, Hartmann JR, Storb R. A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. N Engl J Med 1981; 305:846–851.
Hanis R, Feig S, Coccia P, et al. ALL in second complete remission—a CCSG study of maintenance chemotherapy vs marrow transplantation. In: Progress in Bone Marrow Transplantation, Gale RP, Champlin RE, eds. Alan R Liss, New York, 1987:91–95.
Butturini A, Rivera GK, Bortin MM, Gale RP. Which treatment for childhood acute lymphoblastic leukemia in second remission? Lancet 1987; 1:429–432.
Chessells JM, Rogers DW, Leiper AD, et al. Bone marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukemia. Lancet 1986; 1:1239–1241.
Blume KG, Forman SJ, Snyder DS, et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission. Transplantation 1987; 43:389–392.
Doney K, Buckner CD, Kopecky KJ, et al. Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission. Bone Marrow Transplant 1987; 2:355–363.
Hezig R, Bortin MM, Gluckman E, et al. Optimal timing of bone marrow transplantation in patients with high risk acute lymphoblastic leukemia. Lancet 1987; 1:786–788.
Butturini A, Gale RP. Chemotherapy versus transplantation in acute leukemia. Br J Haematol 1989;72:1–8.
Forman SJ, O’Donnell MR, Nademanee AP, et al. Bone marrow transplantation for patients with Philadeliphia chromosome positive acute lymphoblastic leukemia. Blood 1987; 70: 587–588.
Brochstein JA, Kernan NA, Groshen S, et al. Allogeneic marrow transplantation after hyperfractionated total body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 1987; 317:1618–1624.
Coccia PF, Strandjord SE, Warkentin PI, et al. High-dose cytosine arabinoside and fractionated total body irradiation: An improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in second remission. Blood 1988; 71:888–883.
Blume KG, Forman SJ, O’Donnell MR, et al. Total body irradiation and high dose etoposide: A new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood 1987; 69:1015.
Sullivan KM, Deeg HJ, Sanders J, et al. Hyperacute graft-versus-host disease in patients not given immunuosuppression after allogeneic marrow transplantation. Blood 1986; 67: 1172–1175.
Horowitz MM, Gale RP, Barrett J, et al. Methotrexate prevents relapse after bone marrow transplantation for acute lymphoblastic leukemia. Lancet 1989; 1:535–537.
Bostrom B, Woods WG, Nesbit ME, et al. Successful reinduction of patients with acute lymphoblastic leukemia who relapse following bone marrow transplantation. J Clin Oncol 1987; 5:376–381.
Champlin RE, Ho WG, Lenarsky C, et al. Successful second bone marrow transplants for treatment of acute myelogenous leukemia or acute lymphoblastic leukemia. Transplant Proc 1985; 17:496–499.
Butturini A, Gale RP. T-cell depletion in bone marrow transplantation: Current results, future directions. Bone Marrow Transplant 1988; 3:185–192.
Poynton CH. T-cell depletion in bone marrow transplantation. Bone Marrow Transplant 1988; 3:265–280.
Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cy-closporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314:729–735.
Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1986; 314:1006–1010.
Gingrich RD, Ginder GD, Goeken NE, et al. Allogeneic marrow grafting with mismatched unrelated marrow donors in clinical bone marrow transplantation. Blood 1988; 5:1375–1381.
Office of Technology Assessment. Bone marrow transplantation using unrelated donors: Current clinical status and policy issues. United States Government, Office of Technology Assessment, Washington, DC, 1987:1–46.
Butturini A, Bortin MM, Gale RP. Graft-versus-leukemia following bone marrow transplantation. Bone Marrow Transplant 1987; 2:233–242.
Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions following bone marrow transplantation in human. Blood 1990; In press.
Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304:1529–1532.
Weisdorf DJ, Nesbit NE, Ramsay NKC, et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: Prolonged survival associated with graft-versus-host disease. J Clin Oncol 1987; 5:1348–1355.
Ritz J, Sallan SE, Bast RC, et al. Autologous bone marrow transplantation in CALLA positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Lancet 1982; 2:60–63.
Gorin NC, David R, Strachowiak J, et al. High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. Eur J Cancer 1981; 17:557–568.
Dicke KA, Spitzer G. Clinical studies of autografting in acute lymphoblastic leukemia. Clin Hematol 1986; 15:86–103.
Muirhead M, Martin PJ, Torok-Storb B, Uhr JV, Vitetta ES. Use of an antibody-ricin A chain conjugate to delete neoplastic B cells from human bone marrow. Blood 1983; 62: 327–323.
Treleaven JG, Gibson FM, Ugelstad J. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet 1984; 1:70–83.
Auber ML, Horowitz LJ, Blaauw A, et al. Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia. Blood 1988; 71:166–172.
Sieber F, Stuart RK, Rowley SD, Sharkis SJ, Sensenbrenner LL. Dye mediated photolysis of normal and neoplastic hematopoietic cells. Leuk Res 1987; 11:43–49.
de Fabritis P, Bregni M, Lipton J, et al. Elimination of clonogenic Burkitts lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement. Blood 1985; 65:1064–1070.
Gale RP. Bone marrow purging: Current status, future directions. Bone Marrow Transplant 1987;2(Suppl 2):107–115.
Greaves MF. Differentiation-linked leukemiogenesis in lymphocytes. Science 1986; 234: 697–702.
Goldstone AH, Gribben JG. The role of autologous bone marrow transplantation in the treatment of malignant disease. Blood Rev 1987; 1:193–200.
Burnett AK. Autologous bone marrow transplantation in acute leukemia. Leuk Res 1988; 12:531–536.
Gale RP, Armitage JO, Butturini A. Is there a role for autotransplants in acuite leukemia? Bone Marrow Transplant 1989, 4:217–219.
Gorin NC, Aergerter P, Auvert B, for the EBMTG. Autologous bone marrow transplantation (ABMT) for acute leukemia in remission: Fifth European survey. Evidence in favor of marrow purging. Influence of pretransplant intervals. Bone Marrow Transplant 1988; 3(Suppl 1):39–41.
Beran M, Zander AR. Critical issues in autologous bone marrow transplantation. Eur J Haematol 1987;39:97–117.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Gale, R.P., Butturini, A. (1990). Bone marrow transplantation in acute lymphoblastic leukemia. In: Champlin, R. (eds) Bone Marrow Transplantation. Cancer Treatment and Research, vol 50. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1493-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1493-6_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8803-9
Online ISBN: 978-1-4613-1493-6
eBook Packages: Springer Book Archive